Whilst in non-disease states CA IX expression is limited to the gut epithelium (namely the basolateral surfaces of the cryptic enterocytes), CA IX is ectopically expressed in a variety of neoplastic tissues and knockdown of CA IX expression (or its chemical inhibition) has been shown to reduce primary tumor growth, and decrease drug resistance. The gene discussed is CA9; the disease is neoplasm.